Immunic, Inc. IMUX
Set alert
7.51 USD -0.29 -3.66%
At close
7.50 -0.01 -0.13%
Pre-market · Nov 2, 4:55 AM ET
7.37 Day range 7.78
5.06 52-week range 17.43
- YTD
- +40.64%
- 1 year
- -4.21%
- Open
- 7.70
- Prev close
- 7.80
- Mkt cap
- 102.47M
- Vol
- 244.43K
- Avg vol
- 337.00K
- EPS
- -3.83
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 7.37
- High
- 7.78
- Forward P/E
- -1.67
- Beta
- 1.88
- Short ratio
- 4.69
- Inst. own
- 64.85%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.24
- 200-d avg
- 1.32
- 1y target
- 12.79
News
4 days ago prnewswire.com
Immunic to Host Virtual Progressive Multiple Sclerosis R&D Day on November 5, 2026
NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Immunic , Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced…
-
1 week ago benzinga.com
Cantor Fitzgerald Initiates Coverage On Immunic with Overweight Rating
Cantor Fitzgerald analyst Yanni Souroutzidis initiates coverage on Immunic (NASDAQ:IMUX) with a Overweight rating.
-
3 weeks ago benzinga.com
Immunic Announces Acceptance Of Four Abstracts At MSToronto2026 – the 10th Joint ACTRIMS-ECTRIMS Meeting
Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced that four abstracts highlighting new…